Pubblicazioni

Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?

2021 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Colafigli, Gioia; Scalzulli, Emilia; Di Prima, Alessio; Pepe, Sara; Loglisci, Maria Giovanna; Diverio, Daniela; Martelli, Maurizio; FoÃ , Robin; Breccia, Massimo

Digital droplet PCR as a predictive tool for successful discontinuation outcome in chronic myeloid leukemia: Is it time to introduce it in the clinical practice?

2020 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Colafigli, G.; Scalzulli, E.; Di Prima, A.; Pepe, S.; Loglisci, M. G.; Diverio, D.; Martelli, M.; Foa, R.; Breccia, M.

Current Strategies and Future Directions to Achieve Deep Molecular Response and Treatment-Free Remission in Chronic Myeloid Leukemia

2020 - FRONTIERS IN ONCOLOGY

Annunziata, Mario; Bonifacio, Massimiliano; Breccia, Massimo; Castagnetti, Fausto; Gozzini, Antonella; Iurlo, Alessandra; Pregno, Patrizia; Stagno and Giorgina Specchia, Fabio

Treatment-Free Remission in Chronic Myeloid Leukemia

2019 - CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY

Molica, Matteo; Naqvi, Kiran; Cortes Jorge, E.; Paul, Shilpa; Kadia Tapan, M.; Breccia, Massimo; Kantarjian, Hagop; Jabbour Elias, J.

Prognostic factors associated with a stable MR4.5 achievement in chronic myeloid leukemia patients treated with imatinib

2018 - ONCOTARGET

Breccia, Massimo; Molica, Matteo; Colafigli, Gioia; Massaro, Fulvio; Quattrocchi, Luisa; Latagliata, Roberto; Mancini, Marco; Diverio, Daniela; Guarini, Anna; Alimena, Giuliana; FoÃ , Robin